AEROCOUNT* Dose Counter and AEROCOUNT* Smart Dose Counter
Trudell Medical International is your trusted partner in Dose Counter Technology and Aerosol Drug Delivery, offering two advanced dose counters to help patients manage their medication effectively.
The AEROCOUNT* Dose Counter (TMAI) is a reliable and easy-to-use device that accurately measures the number of doses remaining in an inhaler. Meanwhile, the AEROCOUNT* Smart Dose Counter (eTMAI) is a cutting-edge device that tracks the number of doses remaining in an inhaler, provides reminders and alerts, and connects to smartphones or tablets via Bluetooth. Both dose counters are compatible with a wide range of metered-dose inhalers (MDIs) and provide an essential tool for anyone who relies on MDIs for respiratory therapy. With our expertise in Dose Counter Technology and Aerosol Drug Delivery, we strive to improve the lives of patients with respiratory conditions.
The 1st FDA approved dose counter for MDI developers and the leading choice for your inhalation drug development product. The AERCOUNT* Dose Counter provides patients with a visual indication of remaining medication in their pressurized Metered Dose Inhaler (MDI) and is currently used on 10s of millions of MDIs every year.
The AERCOUNT* Dose Counter is approved by the FDA for use on 8 inhalation drugs and approved internationally, including the EU and Japan, when used in combination with a drug product1.
AEROCOUNT* is customizable and as a result, compatible with a wide range of popular metered dose inhalers (MDIs) components like actuators, canisters, valves, and:
Attaches easily to the canister using a label overwrap
Does not interfere with airflow and aerosol generation
Preserves count integrity of the dose counter to the canister (when cleaning or using multiple inhalers)
Maintains the intuitive and familiar use of an MDI and does not require additional force
Provides a clear, intuitive and easy to read display
Supports easy cleaning and maintenance for patients
Partner with Us
1 AeroCount is approved as part of the Drug Product * trade marks and registered trade marks of Trudell Medical International (TMI). ⓒ2022 TMI. All rights reserved.
2.OPTIMIZING THE DELIVERY OF INHALED MEDICATION FOR RESPIRATORY PATIENTS: THE ROLE OF VALVED HOLDING CHAMBERS. McIvor RA, Devlin HM, Kaplan A. Canadian Respiratory Journal. Volume 2018, Article ID 5076259, 8 pages.
3.Dorinsky P, et al. Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults. Clin Ther. 42 (2020), 634-648.
4.Suggett J et al. The Impact of Inhalation Delay on Lung Drug Delivery: Using Functional Respiratory Imaging (FRI) to Compare Metered Dose Inhaler (MDI) and MDI + Valved Holding Chamber (VHC) Systems. Am J Respir Crit Care Med 2020;201:A5689
5. Suggett J et al. Assessment of potential mouth/ throat deposition and lung delivery of suspension-and solution-formulated inhaled corticosteroid formulations delivered by pressurized metered dose inhaler without and with valved holding chamber using an anatomic adult upper airway. Drug Delivery to the Lungs 28, Dec 2017.
6. Canadian Thoracic Society – 2010 Consensus Summary for children six years of age and over, and adults. 6. Global Strategy for Asthma Management and Prevention 2021 (Global Initiative on Asthma) (www.ginasthma.com)
7. Suggett J et al. A Comparison, Using Functional Respiratory Imaging (FRI), of Adult Airway Deposition Profiles from a Pressurized Metered Dose Inhaler with Valved Holding Chamber (pMDI/VHC) and Two Dry Powder Inhalers (DPI). Respiratory Drug Delivery 2021.
